Patient Safety: Bill Clinton urges healthcare stakeholders not to leave patients “sicker and broke”

Bill Clinton

Former President Bill Clinton addressed an audience of healthcare industry stakeholders last night, asking them to help leave the system better than they found it through coordinated efforts to leverage technology and expertise in the interest of patient health.

Clinton offered the closing remarks of the Patient Safety, Science & Technology Summit in Laguna Beach, Calif., addressing medical device industry executives, clinicians and other healthcare workers gathered to discuss ways medical device interoperability might help prevent the estimated 200,000 annual deaths attributed to medical errors in the U.S. alone.

"I know that none of you want to be part of a system that leaves us sicker and broke," Clinton said. "The promise of science and technology is important, but we have to develop the right mindset – one that says we have to work together, one that says we need networks, one that says we’ve got to share data, not hoard it."

Clinton’s remarks ended a 2-day conference, spearheaded by Masimo‘s (NSDQ:MASI) Foundation for Ethics, Innovation & Competition, focused on medical errors and medical device accessibility.

Masimo founder & CEO Joe Kiani asked other healthcare stakeholders to open up their devices and share the patient data they gather in the interest of improving patient monitoring and care.

Healthcare analysts estimate that roughly 200,000 patients die each year from preventable medical mistakes, including drug dosage errors or failure to act in time to treat a health condition. Kiani asked attendees in Laguna Beach to work toward eliminating all preventable deaths by 2020, a goal that Clinton supported.

"It is not unrealistic to think that by 2020, which I think is your goal, you can get rid of unnecessary deaths in the American healthcare system," Clinton said. "It is not unrealistic, because what happens, based on my experience in other areas, [is] you start slow and then it starts to snowball."

It’s not Clinton’s 1st brush with patient safety and medical error issues. He was in the White House when the Institute of Medicine in 1999 released its 1st formal analysis of medical errors and their impact on healthcare in the U.S., "To Err is Human."

That report estimated that there were between 44,000 and 98,000 preventable deaths in the U.S. each year, including 7,000 due to medication errors alone. The report further estimated that the annual cost of preventable adverse events was north of $17 billion annually and may have reached $29 billion.

At the lower range of 44,000, preventable deaths still beat breast cancer and motor vehicle accidents as a leading cause of death.

Then-President Clinton accepted the majority of the IOM’s recommendations, which included the establishment of a Center for Patient Safety within the Agency for Healthcare Research & Quality, the creation of both mandatory and voluntary reporting systems and the creation of safety systems within healthcare organizations to address ways to bolster efforts at every level of care. He also ordered a feasibility study on the implementation of the IOM suggestions and signed a bill authorizing funding for a revamped Agency for Healthcare Research & Quality. And the Clinton administration published a larger proposal for addressing medical errors and charged the Quality Interagency Coordination task force with the task of coordinating quality improvement activities among a handful of healthcare agencies.

Clinton last night again emphasized the need for cooperation among various healthcare sectors, even among competing organizations, in developing strategies to address patient safety concerns.

"If you keep together as a network, you can change the world," the 42nd U.S. president said. "If you do it right, you will, without even trying, also put a brake on medical inflation, increase quality of care, enhance wellness and help us to become more competitive in the 21st century world – before we pay a terrible price.

"The very lifeblood of this country depends on us unpacking a lot of these healthcare riddles," Clinton said.

RSS From Medical Design & Outsourcing

  • Athermal laser machining cuts bioabsorbable polymers and more
    A the recent MD&M East trade show in New York, Norman Noble, discussed the capability of athermal laser manufacturer. The company has developed the Noble S.T.E.A.L.T.H. (System To Enable Ablation Laser Technology Haz-free). The athermal laser machining process was developed to create precise features in any material, including bioabsorbable polymers, shape memory metals and other […]
  • Exciting possibilities for metallic glass in the medical device world
    Researchers are exploring the potential of metallic glass as a versatile, pliable material that is stronger than steel, with a bevy of possible medical device applications. Yale University engineers have discovered a unique method for designing metallic glass nanostructures across a wide range of chemicals, a technique that could have applications for everything from watch […]
  • Strong Precision Technologies’ medical divisions to unify under MedTorque brand
    Strong Precision Technologies announced on July 2, 2015, that its two medical divisions will now go to market under a single brand, MedTorque. The move reflects the increasing integration of the division formerly known as Inland Midwest with MedTorque, its sister division in Kenosha, WI. “We will continue providing our customers with the personalized level of service […]
  • Olympus offers next-day product replacement guarantee for medical devices
    Olympus, a medical and surgical procedures solutions company, announced that it is guaranteeing next-day replacements for surgical equipment at no additional charge. Olympus is the first surgical product manufacturer to offer this type of guarantee. The service became available to customers with an Olympus Full Service Agreement earlier this year. “Canceled procedures can be costly for healthcare facilities […]
  • More accurate prediction on prognosis in multiple myeloma from SkylineDx
    SkylineDx, a biotechnology company specializing in the development and commercialization of genetic tests, is launching its MMprofiler assay. This test enables clinicians to more accurately predict the prognosis of patients with multiple myeloma (bone marrow cancer) than traditional methods. The MMprofiler measures the activity of 92 genes which are directly or indirectly related to the […]
  • Flint Mobile swaps card reader for camera, accept mobile payments anywhere
    Flint Mobile, the swipe-free mobile payments app, has significantly expanded its payment management and loyalty capabilities for small, service-centric businesses, like the ones run by on-the-go medical equipment professionals. The toggle-free mobile technology makes the process quite simple for both parties, as all transactions are conducted through the mobile device’s camera without the need of any external […]
  • Should scientists be allowed to genetically alter human embryos?
    Scientists have at their disposal, a way to explore the possible prevention of genetic diseases before birth. But should they? Currently, the most promising path forward involves editing the genes of human embryos, a procedure threaded with controversy. An article in “Chemical & Engineering News” (C&EN), the weekly newsmagazine of the American Chemical Society (ACS), parses […]
  • Tackling chronic sinusitis by addressing underlying factors
    The stuffy noses and sinus pressure of head colds are uncomfortable, but for most people, they go away within days. For those with chronic sinusitis, however, those symptoms and others drag on for weeks. Now scientists are onto a potential new therapy that could address one of the underlying factors associated with the condition. They […]
  • Implantable “artificial pancreas” could help diabetes patients control their blood sugar
    Living with Type 1 diabetes requires constant monitoring of blood sugar levels and injecting insulin daily. Now scientists are reporting in the American Chemical Society (ACS) journal, “Industrial & Engineering Chemistry Research,” the development of an implantable “artificial pancreas” that continuously measures a person’s blood sugar or glucose level and can automatically release insulin as […]
  • Drug Deactivation program roll out to all facilities for safe disposal of unused prescription medications
    Verde Technologies announced that New Brighton-based Meridian Behavioral Health, the largest for-profit substance abuse and addiction treatment group in Minnesota, has become its most recent partner in the deactivation and safe disposal of prescription medications including methadone. Meridian is the first behavioral health group to roll out the Deterra Drug Deactivation System to all 17 […]
  • Lophius Biosciences introduces T-activated ImmunoScan Cocktail
    Lophius Biosciences announced the commercial launch of T-Track ImmunoScan and T-activated ImmunoScan Cocktail. Based on a proprietary and very specific cocktail of stimulants in combination with the Company’s T-activation technology, T-Track ImmunoScan and T-activated ImmunoScan Cocktail specifically target different cell types involved in both the adaptive and innate immune system. T-Track ImmunoScan and the T-activated […]

Leave a Reply